Pronerve growth factor induces angiogenesis via activation of trka: Possible role in proliferative diabetic retinopathy

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Elshaer, Sally L ^a,b,c   Abdelsaid, Mohammed A ^a,b,c   Al Azayzih, Ahmad ^a,c   Kumar, Parag ^a,d   Matragoon, Suraporn ^a,b,c   Nussbaum, Julian J ^b   El Remessy, Azza B ^a,b,c  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE P38; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR P75; PROTEIN TYROSINE KINASE A; PRO NERVE GROWTH FACTOR, HUMAN; PRO-NERVE GROWTH FACTOR, HUMAN; PROTEIN PRECURSOR;

ANGIOGENESIS; AQUEOUS HUMOR; ARTICLE; BLINDNESS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ADOLESCENT; ADULT; CELL MOTION; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHOSPHORYLATION; PHYSIOLOGY;

ADOLESCENT; ADULT; AQUEOUS HUMOR; CELL MOVEMENT; CELL PROLIFERATION; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTOR; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PRECURSORS; RECEPTOR, TRKA;

EID: 84884264804     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/432659     Document Type: Article

References (59)

1. Bressler N. M., Edwards A. R., Beck R. W., Flaxel C. J., Glassman A. R., Ip M. S., Kollman C., Kuppermann B. D., Stone T. W., Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation. Archives of Ophthalmology 2009 127 12 1566 1571 2-s2.0-73349135368 10.1001/archophthalmol.2009.308
2. Ali T. K., El-Remessy A. B., Diabetic retinopathy: current management and experimental therapeutic targets. Pharmacotherapy 2009 29 2 182 192 2-s2.0-59949099437 10.1592/phco.29.2.182
3. Noma H., Funatsu H., Yamasaki M., Tsukamoto H., Mimura T., Sone T., Hirayama T., Tamura H., Yamashita H., Minamoto A., Mishima H. K., Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 2008 22 1 42 48 2-s2.0-38349179299 10.1038/sj.eye.6702498
4. Kroll P., Rodrigues E. B., Hoerle S., Pathogenesis and classification of proliferative diabetic vitreoretinopathy. Ophthalmologica 2007 221 2 78 94 2-s2.0-33947504474 10.1159/000098253
5. Whitmire W., Al-Gayyar M. M. H., Abdelsaid M., Yousufzai B. K., El-Remessy A. B., Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far. Molecular Vision 2011 17 300 308 2-s2.0-79551705529
6. Tang J., Kern T. S., Inflammation in diabetic retinopathy. Progress in Retinal and Eye Research 2011 30 5 343 358 2-s2.0-79960190061 10.1016/j.preteyeres.2011.05.002
7. El-Remessy A. B., Al-Shabrawey M., Khalifa Y., Tsai N.-T., Caldwell R. B., Liou G. I., Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. American Journal of Pathology 2006 168 1 235 244 2-s2.0-30344486638 10.2353/ajpath.2006.050500
8. Ola M. S., Nawaz M. I., El-Asrar A. A., Abouammoh M., Alhomida A. S., Reduced levels of brain derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and in the retina of diabetic rats. Cellular and Molecular Neurobiology 2013 33 359 367
9. Park K. S., Kim S. S., Kim J. C., Kim H. C., Im Y. S., Ahn C. W., Lee H. K., Serum and tear levels of nerve growth factor in diabetic retinopathy patients. American Journal of Ophthalmology 2008 145 3 432 437 2-s2.0-39049151766 10.1016/j.ajo.2007.11.011
10. Ali T. K., Al-Gayyar M. M. H., Matragoon S., Pillai B. A., Abdelsaid M. A., Nussbaum J. J., El-Remessy A. B., Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury. Diabetologia 2011 54 3 657 668 2-s2.0-79953749538 10.1007/s00125-010-1935-1
11. Al-Gayyar M. M. H., Matragoon S., Pillai B. A., Ali T. K., Abdelsaid M. A., El-Remessy A. B., Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor proNGF expression in a rat model of diabetes. Diabetologia 2011 54 3 669 680 2-s2.0-79953764493 10.1007/s00125-010-1994-3
12. Micera A., Lambiase A., Stampachiacchiere B., Bonini S., Bonini S., Levi-Schaffer F., Nerve growth factor and tissue repair remodeling: trkA NGFR and p75 NTR, two receptors one fate. Cytokine and Growth Factor Reviews 2007 18 3-4 245 256 2-s2.0-34250199737 10.1016/j.cytogfr.2007.04.004
13. Micera A., Lambiase A., Puxeddu I., Aloe L., Stampachiacchiere B., Levi-Schaffer F., Bonini S., Bonini S., Nerve growth factor effect on human primary fibroblastic-keratocytes: possible mechanism during corneal healing. Experimental Eye Research 2006 83 4 747 757 2-s2.0-33748162256 10.1016/j.exer.2006.03.010
14. Graiani G., Emanueli C., Desortes E., Van Linthout S., Pinna A., Figueroa C. D., Manni L., Madeddu P., Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of type 1 diabetic mice. Diabetologia 2004 47 6 1047 1054 2-s2.0-3142667690
15. Meloni M., Caporali A., Graiani G., Lagrasta C., Katare R., Van Linthout S., Spillmann F., Campesi I., Madeddu P., Quaini F., Emanueli C., Nerve growth factor promotes cardiac repair following myocardial infarction. Circulation Research 2010 106 7 1275 1284 2-s2.0-77951298253 10.1161/CIRCRESAHA.109.210088
16. von Bartheld C. S., Neurotrophins in the developing and regenerating visual system. Histology and Histopathology 1998 13 2 437 459 2-s2.0-0031969285
17. Blais M., Lévesque P., Bellenfant S., Berthod F., Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model. Tissue Engineering A 2013 19 15-16 1655 1664 10.1089/ten.tea.2012.0745
18. Jadhao C. S., Bhatwadekar A. D., Jiang Y., Boulton M. E., Steinle J. J., Grant M. B., Nerve growth factor promotes endothelial progenitor cell-mediated angiogenic responses. Investigative Ophthalmology & Visual Science 2012 53 2030 2037
19. Lee R., Kermani P., Teng K. K., Hempstead B. L., Regulation of cell survival by secreted proneurotrophins. Science 2001 294 5548 1945 1948 2-s2.0-0035976524 10.1126/science.1065057
20. Abdelsaid M. A., Pillai B. A., Matragoon S., Prakash R., Al-Shabrawey M., El-Remessy A. B., Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy. The Journal of Pharmacology and Experimental Therapeutics 2010 332 1 125 134 2-s2.0-73949127943 10.1124/jpet.109.157941
21. LeSauteur L., Wei L., Gibbs B. F., Saragovi H. U., Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. The Journal of Biological Chemistry 1995 270 12 6564 6569 2-s2.0-0028912281 10.1074/jbc.270.12.6564
22. Abdelsaid M. A., El-Remessy A. B., S-glutathionylation of LMW-PTP regulates VEGF-mediated FAK activation and endothelial cell migration. Journal of Cell Science 2012 125 4751 4760 10.1242/jcs.103481
23. El-Remessy A. B., Al-Shabrawey M., Platt D. H., Bartoli M., Behzadian M. A., Ghaly N., Tsai N., Motamed K., Caldwell R. B., Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells. FASEB Journal 2007 21 10 2528 2539 2-s2.0-34547788817 10.1096/fj.06-7854com
24. Kozak A., Ergul A., El-Remessy A. B., Johnson M. H., Machado L. S., Elewa H. F., Abdelsaid M., Wiley D. C., Fagan S. C., Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke. Stroke 2009 40 5 1870 1876 2-s2.0-65549163364 10.1161/STROKEAHA.108. 537225
25. Liu X., Wang D., Liu Y., Luo Y., Ma W., Xiao W., Yu Q., Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model. Investigative Ophthalmology & Visual Science 2010 51 7 3749 3757 2-s2.0-77955867263 10.1167/iovs.09-4226
26. Kim H., Li Q., Hempstead B. L., Madri J. A., Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells. The Journal of Biological Chemistry 2004 279 32 33538 33546 2-s2.0-4043109885 10.1074/jbc.M404115200
27. Ali T. K., Matragoon S., Pillai B. A., Liou G. I., El-Remessy A. B., Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 2008 57 4 889 898 2-s2.0-42449100783 10.2337/db07-1669
28. Loukovaara S., Robciuc A., Holopainen J. M., Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGF β 1 in diabetic eyes undergoing vitrectomy. Acta Ophthalmologica 2012 10.1111/j.1755-3768.2012.02473.x
29. Mohan N., Monickaraj F., Balasubramanyam M., Rema M., Mohan V., Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy. Journal of Diabetes and Its Complications 2012 26 435 441 10.1016/j.jdiacomp. 2012.05.005
30. Suzuki Y., Nakazawa M., Suzuki K., Yamazaki H., Miyagawa Y., Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Japanese Journal of Ophthalmology 2011 55 3 256 263 2-s2.0-79960072567 10.1007/s10384-011-0004-8
31. Elewa H. F., El-Remessy A. B., Somanath P. R., Fagan S. C., Diverse effects of statins on angiogenesis: new therapeutic avenues. Pharmacotherapy 2010 30 2 169 176 2-s2.0-75849116284 10.1592/phco.30.2.169
32. Boodhwani M., Sellke F. W., Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress. Antioxidants & Redox Signaling 2009 11 8 1945 1959 2-s2.0-67650254143 10.1089/ars.2009.2439
33. Emanueli C., Madeddu P., Therapeutic angiogenesis: translating experimental concepts to medically relevant goals. Vascular Pharmacology 2006 45 5 334 339 2-s2.0-33751095069 10.1016/j.vph.2006.08.012
34. Salis M. B., Graiani G., Desortes E., Caldwell R. B., Madeddu P., Emanueli C., Nerve growth factor supplementation reverses the impairment, induced by type 1 diabetes, of hindlimb post-ischaemic recovery in mice. Diabetologia 2004 47 6 1055 1063 2-s2.0-3142714528
35. Azar S. T., Major S. C., Safieh-Garabedian B., Altered plasma levels of nerve growth factor and transforming growth factor- β 2 in type-1 diabetes mellitus. Brain, Behavior, and Immunity 1999 13 4 361 366 2-s2.0-0033406199 10.1006/brbi.1999.0554
36. Cantarella G., Lempereur L., Presta M., Ribatti D., Lombardo G., Lazarovici P., Zappalà G., Pafumi C., Bernardini R., Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB Journal 2002 16 10 1307 1309 2-s2.0-0036674499
37. Dollé J.-P., Rezvan A., Allen F. D., Lazarovici P., Lelkes P. I., Nerve growth factor-induced migration of endothelial cells. The Journal of Pharmacology and Experimental Therapeutics 2005 315 3 1220 1227 2-s2.0-27844605447 10.1124/jpet.105.093252
38. Lazarovici P., Gazit A., Staniszewska I., Marcinkiewicz C., Lelkes P. I., Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane. Endothelium 2006 13 1 51 59 2-s2.0-33646505056 10.1080/ 10623320600669053
39. Alhusban A., Kozak A., Ergul A., Fagan S. C., AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. The Journal of Pharmacology and Experimental Therapeutics 2013 344 348 359 10.1124/jpet.112.197483
40. Shen L., Zeng W., Wu Y. X., Neurotrophin-3 accelerates wound healing in diabetic mice by promoting a paracrine response in mesenchymal stem cells. Cell Transplantation 2012 22 6 1011 1021 10.3727/096368912X657495
41. Demont Y., Corbet C., Page A., Ataman-Önal Y., Choquet-Kastylevsky G., Fliniaux I., Le Bourhis X., Toillon R.-A., Bradshaw R. A., Hondermarck H., Pro-nerve growth factor induces autocrine stimulation of breast cancer cell invasion through tropomyosin-related kinase A (TrkA) and sortilin protein. The Journal of Biological Chemistry 2012 287 3 1923 1931 2-s2.0-84855833498 10.1074/jbc.M110.211714
42. Berg M. M., Sternberg D. W., Parada L. F., Chao M. V., K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity. The Journal of Biological Chemistry 1992 267 1 13 16 2-s2.0-0026512998
43. Yoon S. O., Soltoff S. P., Chao M. V., A dominant role of the juxtamembrane region of the TrkA nerve growth factor receptor during neuronal cell differentiation. The Journal of Biological Chemistry 1997 272 37 23231 23238 2-s2.0-0010403657 10.1074/jbc.272.37.23231
44. Lagadec C., Meignan S., Adriaenssens E., Foveau B., Vanhecke E., Romon R., Toillon R.-A., Oxombre B., Hondermarck H., Le Bourhis X., TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene 2009 28 18 1960 1970 2-s2.0-66149157927 10.1038/onc.2009.61
45. Freund-Michel V., Bertrand C., Frossard N., TrkA signalling pathways in human airway smooth muscle cell proliferation. Cellular Signalling 2006 18 5 621 627 2-s2.0-30944441220 10.1016/j.cellsig.2005.06.007
46. Baker S. J., Reddy E. P., Modulation of life and death by the TNF receptor superfamily. Oncogene 1998 17 25 3261 3270 2-s2.0-0032428331
47. Cragnolini A. B., Friedman W. J., The function of p75 NTR in glia. Trends in Neurosciences 2008 31 2 99 104 2-s2.0-39149136861 10.1016/j.tins.2007.11.005
48. Ibáez C. F., Jekyll-Hyde neurotrophins: the story of proNGF. Trends in Neurosciences 2002 25 6 284 286 2-s2.0-0036602976 10.1016/S0166- 2236(02)02169-0
49. Roux P. P., Barker P. A., Neurotrophin signaling through the p75 neurotrophin receptor. Progress in Neurobiology 2002 67 3 203 233 2-s2.0-0036344505 10.1016/S0301-0082(02)00016-3
50. Al-Gayyar M. M. H., Mysona B. A., Matragoon S., Diabetes and overexpression of proNGF cause retinal neurodegeneration via activation of RhoA pathway. PLoS One 2013 8 1 e54692 10.1371/journal.pone.0054692
51. El-Remessy A. B., Al-Gayyar M. M. H., Matragoon S., Saragovi H. U., Overexpression of ProNGF induces apoptosis and acellular capillary formation via activation of p75 NTR. Investigative Ophthalmology & Visual Science 2012 53, article 5570
52. Kenchappa R. S., Zampieri N., Chao M. V., Barker P. A., Teng H. K., Hempstead B. L., Carter B. D., Ligand-dependent cleavage of the P75 neurotrophin receptor is necessary for NRIF nuclear translocation and apoptosis in sympathetic neurons. Neuron 2006 50 2 219 232 2-s2.0-33646052860 10.1016/j.neuron.2006.03.011
53. Matragoon S., Al-Gayyar M. M. H., Mysona B. A., Electroporation-mediated gene delivery of cleavage-resistant pro-nerve growth factor causes retinal neuro- and vascular degeneration. Molecular Vision 2012 18 2993 3003
54. Lebrun-Julien F., Bertrand M. J., de Backer O., Stellwagen D., Morales C. R., Di Polo A., Barker P. A., ProNGF induces TNF α -dependent death of retinal ganglion cells through a p75 NTR non-cell-autonomous signaling pathway. Proceedings of the National Academy of Sciences of the United States of America 2010 107 8 3817 3822 2-s2.0-77649249857 10.1073/pnas.0909276107
55. Mysona B. A., Abdelsaid M. A., Matragoon S., Pillai B. A., El-Remessy A. B., Inflammatory role of ProNGF/ p75 NTR in muller cells of the diabetic retina. Investigative Ophthalmology & Visual Science 2012 53, article 2003
56. Caporali A., Pani E., Horrevoets A. J. G., Kraenkel N., Oikawa A., Sala-Newby G. B., Meloni M., Cristofaro B., Graiani G., Leroyer A. S., Boulanger C. M., Spinetti G., Yoon S. O., Madeddu P., Emanueli C., Neurotrophin p75 receptor (p75 NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles. Circulation Research 2008 103 2 e15 e26 2-s2.0-48849107004 10.1161/CIRCRESAHA.108.177386
57. Grade S., Weng Y. C., Snapyan M., Kriz J., Malva J. O., Saghatelyan A., Brain-derived neurotrophic factor promotes vasculature-associated migration of neuronal precursors toward the ischemic striatum. PLoS ONE 2013 8 1 e55039 10.1371/journal.pone.0055039
58. Snapyan M., Lemasson M., Brill M. S., Blais M., Massouh M., Ninkovic J., Gravel C., Berthod F., Götz M., Barker P. A., Parent A., Saghatelyan A., Vasculature guides migrating neuronal precursors in the adult mammalian forebrain via brain-derived neurotrophic factor signaling. The Journal of Neuroscience 2009 29 13 4172 4188 2-s2.0-65249118446 10.1523/JNEUROSCI.4956-08. 2009
59. Meuchel L. W., Thompson M. A., Cassivi S. D., Pabelick C. M., Prakash Y. S., Neurotrophins induce nitric oxide generation in human pulmonary artery endothelial cells. Cardiovascular Research 2011 91 4 668 676 2-s2.0-80051976998 10.1093/cvr/cvr107